AKT1 and prostate cancer: Moreover, AB56αC/methylation-sensitive heterotrimers negatively regulate the PI3K-AKT-mTOR-S6K signaling axis, and a high proportion of prostate cancers exhibit increased activation of this critical survival pathway17,20,24,37,38.